# Oral Switch During Treatment of Left-sided Endocarditis Due to Multi-susceptible Staphylococcus

> **NCT02701608** · PHASE3 · COMPLETED · sponsor: **University Hospital, Tours** · enrollment: 162 (actual)

## Conditions studied

- Infective Endocarditis

## Interventions

- **DRUG:** Levofloxacin
- **DRUG:** Rifampicin
- **PROCEDURE:** Conventional IV treatment of staphylococci IE following European guidelines 2015 including cloxacilline, oxacilline,gentamicine,vancomycine,rifampicine

## Key facts

- **NCT ID:** NCT02701608
- **Lead sponsor:** University Hospital, Tours
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-02-29
- **Primary completion:** 2024-08-15
- **Final completion:** 2024-12-04
- **Target enrollment:** 162 (ACTUAL)
- **Last updated:** 2026-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02701608

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02701608, "Oral Switch During Treatment of Left-sided Endocarditis Due to Multi-susceptible Staphylococcus". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02701608. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*